Amanda Nizam, Associate Staff of Genitourinary Medical Oncology at Cleveland Clinic, shared on X:
“Discussion of Beth Nally’s eloquent ASCO 2026 presentation on redefining toxicity assessments in oncology. CTCAE doesn’t capture the whole story. Cumulative incidence and point prevalence of TRAEs needed to better capture chronic toxicity burden over time.
More granular toxicity data including time to onset, severity, duration, resolution rate, time to resolution, and PROs would improve Tx counseling.”
Find out more:
